Reynolds Cameron John 4
4 · VOLITIONRX LTD · Filed Feb 27, 2026
Research Summary
AI-generated summary of this filing
VolitionRx (VNRX) CEO Cameron Reynolds Receives RSU Award
What Happened Cameron Reynolds, President & CEO and a director of VolitionRx Ltd. (VNRX), was awarded 486,000 restricted stock units (RSUs) on Feb 26, 2026. The grant was reported as an award (code A) at a reported price of $0.00 (awarded in lieu of cash), so no cash was exchanged at grant.
Key Details
- Transaction date: February 26, 2026; Form 4 filed February 27, 2026 (timely).
- Award: 486,000 RSUs; reported price $0.00; reported value at grant $0.
- Vesting/settlement: RSUs are earned in 12 approximately equal monthly installments beginning March 1, 2026; once earned they remain subject to additional time-based vesting in a single installment on February 26, 2027. Continued service is required to earn and vest.
- Shares on settlement: Upon vesting and settlement, each RSU converts into one share of common stock.
- Shares owned after transaction: Not specified in this filing.
- Holding/beneficial control: The filing notes the shares are held directly by Concord International, Inc.; Mr. Reynolds is the majority shareholder of Concord and shares voting and dispositive control over those shares.
Context This was an equity compensation award (RSUs) issued in lieu of cash compensation — a routine form of executive pay, not an open-market purchase or sale. The RSUs only convert to actual shares if and when the specified earning and vesting conditions are met, so this award does not immediately change Mr. Reynolds’s freely tradable holdings.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-26+486,000→ 3,115,547 total
- 1,007,718(indirect: By Concord International, Inc.)
Common Stock
[F2] - 34,076(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]On February 26, 2026, the reporting person was awarded 486,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date.
- [F2]The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.